licensing and royalty revenue from the sale of our customers' products that incorporate technology developed through our CDPs.Our StrategyOur mission is to drive our customers' success by transforming R&D and accelerating innovation in markets that derive competitive
are:•Target large, high-volume semiconductor markets;•Target large, high-growth, emerging clean-energy markets;•Engage with existing and potential market leaders in our target markets;•Create proprietary IP with our customers;•Enhance our HPC platform and multi-disciplinary team; and•Explore and develop new technologies in high-volume integrated devices.4Table of ContentsRisks Related to Our Financial Condition and BusinessOur business is subject to a number of risks and uncertainties that you should understand before making an investment decision.
and may result in volatility in the market price of our common stock if we fail to meet the expectations of public market analysts and investors in these periods;•We have incurred operating losses since our inception and may not be able to achieve or maintain profitability;•We depend on a limited number of customers, which have historically been in the semiconductor industry, and a loss of any
One or more failures to enter into a CDP after we have devoted significant resources to a project could adversely affect our business and operating results;•The semiconductor industry is rapidly changing and an inability to evolve existing products in a timely manner, anticipate
resulting in the issuance of 1,313,492 shares of common stock for an aggregate exercise price of approximately $6.4 million; and•no exercise of the underwriters' over-allotment option.8Table of ContentsSummary Consolidated Financial DataThe following table sets forth a summary of our historical consolidated financial data for the periods ended or as of the dates
indicative of results to be expected for the full year.Years Ended December 31,Nine Months EndedSeptember 30,20082009201020102011(unaudited)(in thousands, except share and per share amounts)Consolidated Statement of Operations Data:Revenue:CDP and services revenue$14,647$14,182$27,705$17,992$26,169Product revenue6,2069,0656,9594,9352,038Licensing and royalty revenue2,2763,6638,0105,58310,491Total revenue23,12926,91042,67428,51038,698Cost of revenue12,62513,01820,92613,98817,999Gross profit10,50413,89221,74814,52220,699Operating expenses:Research and development11,84910,98313,91710,21714,601Sales and marketing3,8493,2114,0743,0563,229General and administrative4,3004,8675,7614,2506,156Total operating expenses19,99819,06123,75217,52323,986Loss from operations(9,494)(5,169)(2,004)(3,001)(3,287)Other income (expense):Interest income, net174(6)433716Other income (expense), net6(62)20271(1,174)Total other income (expense), net180(68)245108(1,158)Loss before provision for income taxes(9,314)(5,237)(1,759)(2,893)(4,445)Provision for income taxes1861719819Net loss(9,500)(5,254)(1,778)(2,901)(4,464)Accretion on redeemable convertible preferred stock(5,436)(9,170)(14,162)(10,044)(8,660)Net loss attributable to common stockholders$(14,936)$(14,424)$(15,940)$(12,945)$(13,124)Net loss per share of common stock, basic and diluted$(2.97)$(2.62)$(2.86)$(2.33)$(2.30)Weighted-average number of shares used in computing net loss per share of common stock, basic and diluted(1)5,024,1185,511,8895,567,2865,555,4485,716,511Pro forma net loss per share of common stock, basic and diluted(1)$(0.05)$(0.11)Weighted-average number of shares used in computing pro forma net loss per share of common stock, basic and diluted(1)32,688,16034,885,617Other Data:Adjusted EBITDA(2)(unaudited)$(5,062)$272$4,589$1,740$4,1969Table of ContentsAs of September 30, 2011ActualPro Forma(3)Pro Forma asAdjusted(4)(unaudited)(in thousands)Consolidated Balance Sheet Data:Cash, cash equivalents and short-term investments$29,511$35,888$99,210Working capital17,19024,47675,794Total assets73,65680,033143,313Note payable——15,413Preferred stock warrant liability909——Redeemable convertible preferred stock80,515——Accumulated accretion of redeemable convertible preferred stock to redemption values43,086——Total stockholders' (deficit) equity(74,992)55,895107,213(1)Please
following table presents a reconciliation of adjusted EBITDA to our net loss, the most comparable GAAP measure, for each of the periods indicated:Years Ended December 31,Nine MonthsEndedSeptember 30,20082009201020102011(unaudited)(in thousands)Net loss$(9,500)$(5,254)$(1,778)$(2,901)$(4,464)Non-GAAP adjustments:Revenue(a)————312Interest, net(94)4813(37)678Provision for taxes1861719819Mark-to-market of derivative liability————609Depreciation and amortization3,4304,3804,9713,6425,239Stock-based compensation expense(b)9161,0811,3641,0281,803Adjusted EBITDA (unaudited)$(5,062)$272$4,589$1,740$4,196(a)Reduction
of our common stock if we fail to meet the expectations of public market analysts and investors in these periods.Our revenue, expenses and operating results have fluctuated, and may in the future fluctuate significantly from quarter to quarter due
prospectus:•our dependence on a limited number of customers;•our ability to manage our growth, including an increasing number of employees, customers and CDPs;•the length of our sales and development cycles, and our ability to generate material revenue after we have devoted
addition, we expect to continue to incur significant expenses or revenue adjustments in connection with, among other things:•increased R&D spending, including expansion of our R&D teams and workflow platforms;•expansion of our sales and marketing efforts;•additional non-cash charges relating to amortization of intangibles and deferred stock compensation; and•one-time, non-cash charges to revenue associated with the vesting of contingent warrants issued to
Our future operating results will also depend on our management's ability to:•implement and improve our sales, marketing and customer support programs and our R&D efforts;•enhance our operational and financial control systems;•expand, train and manage our employee base;•integrate any acquired businesses; and•effectively address new issues related to our growth as they arise.We
If we are unable to maintain the royalty-bearing license aspect of our business model, our operating results would suffer and we may not achieve profitability.Our sales cycles are long, and we commit significant resources to a project before we have any commitment that a potential customer may agree to use our platform or service.
collaborations with companies who are ultimately unsuccessful in the clean-energy industry, which could adversely affect our operating results.If a project to which we have devoted technology and significant resources fails to produce any measurable success or value to our customers in the form of differentiated
able to commercialize, there may be a significant delay before we receive any licensing or royalty revenue due to the complexities inherent in production and manufacturing in our target markets.A decline in sales in the end markets for products incorporating technology developed through our CDPs could adversely affect our business and results of operations.Our success is tied to our customers' ability to successfully commercialize the products that incorporate technology developed through
could adversely affect our ability to enter into new CDPs and cause our revenue and operating results to decline.We may be unable to make the substantial R&D investments required to remain competitive in our business.The semiconductor and clean-energy industries require substantial investment in R&D to develop and bring to market new and enhanced
Licensing and royalty revenue we may receive in the future may be based on the revenue from the sale of our customers' products that incorporate technology developed through our CDPs,
impacts on our operations and financial condition.In the future, exchange rate fluctuations could affect our revenue, which could adversely affect our business and operating results.Our licensing and royalty revenue is derived from sales of our customers' products that incorporate technology developed through our
prospectus.44Table of ContentsYears Ended December 31,Nine Months Ended September 30,2006200720082009201020102011(unaudited)(in thousands, except share and per share amounts)Consolidated Statement of Operations Data:Revenue:CDP and services revenue$3,628$8,594$14,647$14,182$27,705$17,992$26,169Product revenue——6,2069,0656,9594,9352,038Licensing and royalty revenue——2,2763,6638,0105,58310,491Total revenue3,6288,59423,12926,91042,67428,51038,698Cost of revenue1,9924,87312,62513,01820,92613,98817,999Gross profit1,6363,72110,50413,89221,74814,52220,699Operating expenses:Research and development5,1759,41511,84910,98313,91710,21714,601Sales and marketing7731,5413,8493,2114,0743,0563,229General and administrative3,6473,8374,3004,8675,7614,2506,156Total operating expenses9,59514,79319,99819,06123,75217,52323,986Loss from operations(7,959)(11,072)(9,494)(5,169)(2,004)(3,001)(3,287)Other income (expense):Interest income, net448850174(6)433716Other income (expense), net——6(62)20271(1,174)Total other income (expense), net448850180(68)245108(1,158)Loss before provision for income taxes(7,511)(10,222)(9,314)(5,237)(1,759)(2,893)(4,445)Provision for income taxes111861719819Net loss(7,512)(10,223)(9,500)(5,254)(1,778)(2,901)(4,464)Accretion on redeemable convertible preferred stock(1,351)(4,168)(5,436)(9,170)(14,162)(10,044)(8,660)Net loss attributable to common stockholders$(8,863)$(14,391)$(14,936)$(14,424)$(15,940)$(12,945)$(13,124)Net loss per share of common stock, basic and diluted$(1.98)$(3.17)$(2.97)$(2.62)$(2.86)$(2.33)$(2.30)Weighted-average number of shares used in computing net loss per share of common stock, basic and diluted(1)4,484,3284,542,7625,024,1185,511,8895,567,2865,555,4485,716,511Pro forma net loss per share of common stock, basic and diluted(1)$(0.05)$(0.11)Weighted-average number of shares used in computing pro forma net loss per share of common stock, basic and diluted(1)32,688,16034,885,617Other Data:Adjusted EBITDA (unaudited)$(5,238)$(7,737)$(5,062)$272$4,589$1,740$4,196Years Ended December 31,As of September 30,201120062007200820092010(unaudited)(in thousands)Consolidated Balance Sheet Data:Cash, cash equivalents and short-term investments$20,698$26,744$40,902$32,620$23,064$29,511Working capital22,51918,55226,66316,3894,82517,190Total assets28,90640,87762,19054,46955,57173,656Long-term debt, including current portion—3,1944,445———Preferred stock warrant liability———159215909Redeemable convertible preferred stock35,73835,73855,63355,63355,63380,515Accumulated accretion of redeemable convertible preferred stock to redemption values1,4905,65811,09420,26434,42643,086Total stockholders' deficit(9,629)(22,706)(36,579)(49,889)(64,356)(74,992)(1)Please